Evidence map›Paper›PMID 37752102›Full record

ArticleNature communications2023

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Philip Smith, Thomas Bradley, Lena Morrill Gavarró, Teodora Goranova, Darren P Ennis, Hasan B Mirza, Dilrini De Silva, Anna M Piskorz, Carolin M Sauer, Sarwah Al-Khalidi and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Philip Smith *CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9306-1747
Thomas Bradley *CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-0218-5021
Lena Morrill GavarróCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-2242-4010
Teodora GoranovaCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
Darren P EnnisOvarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
Hasan B MirzaOvarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-6460-5290
Dilrini De SilvaCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
Anna M PiskorzCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
Carolin M SauerCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-2168-6630
Sarwah Al-KhalidiCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
Ionut-Gabriel FuninganaCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-1197-2652
Marika A V ReiniusCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9778-3317
Gaia GiannoneOvarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
Liz-Anne LewsleyCRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Jamie StoboCRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
John McQueenCRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Gareth BrysonDepartment of Histopathology, Queen Elizabeth University Hospital, Glasgow, UK.
Matthew EldridgeCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-5799-8911
BriTROC Investigators
Geoff MacintyreCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-3906-467X
Florian MarkowetzCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-2784-5308
James D BrentonCRUK Cambridge Institute, University of Cambridge, Cambridge, UK. james.brenton@cruk.cam.ac.uk.ORCID http://orcid.org/0000-0002-5738-6683
Iain A McNeishOvarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK. i.mcneish@imperial.ac.uk.ORCID http://orcid.org/0000-0002-9387-7586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37752102
PMCPMC10522588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.